Lysophosphatidic acid-induced Ca2+ mobilization in human A431 cells: structure-activity analysis - PubMed (original) (raw)
Lysophosphatidic acid-induced Ca2+ mobilization in human A431 cells: structure-activity analysis
K Jalink et al. Biochem J. 1995.
Abstract
Lysophosphatidic acid (LPA; 1-acyl-sn-glycero-3-phosphate) is a platelet-derived lipid mediator that activates its own G-protein-coupled receptor to trigger phospholipase C-mediated Ca2+ mobilization and other effector pathways in numerous cell types. In this study we have examined the structural features of LPA that are important for activation of the Ca(2+)-mobilizing receptor in human A431 carcinoma cells, which show an EC50 for oleoyl-LPA as low as 0.2 nM. When the acyl chain at the sn-1 position is altered, the rank order of potency is oleoyl-LPA > arachidonoyl-LPA > linolenoyl-LPA > linoleoyl-LPA > stearoyl-LPA = palmitoyl-LPA > myristoyl-LPA. The shorter-chain species, lauroyl- and decanoyl-LPA, show little or no activity. Ether-linked LPA (1-O-hexadecyl-sn-glycero-3-phosphate) is somewhat less potent than the corresponding ester-linked LPA; its stereoisomer is about equally active. Deletion of the glycerol backbone causes a 1000-fold decrease in potency. Replacement of the phosphate group in palmitoyl-LPA by a hydrogen- or methyl-phosphonate moiety results in complete loss of activity. A phosphonate analogue with a methylene group replacing the oxygen at sn-3 has strongly decreased activity. All three phosphonate analogues induce cell lysis at doses > 15 microM. Similarly, the methyl and ethyl esters of palmitoyl-LPA are virtually inactive and become cytotoxic at micromolar doses. None of the LPA analogues tested has antagonist activity. Sphingosine 1-phosphate, a putative messenger with some structural similarities to LPA, elicits a transient rise in intracellular [Ca2+] only at micromolar doses; however, cross-desensitization experiments indicate that sphingosine 1-phosphate does not act through the LPA receptor. The results indicate that, although many features of the LPA structure are important for optimal activity, the phosphate group is most critical, suggesting that this moiety is directly involved in receptor activation.
Similar articles
- Structure-activity analysis of the effects of lysophosphatidic acid on platelet aggregation.
Gueguen G, Gaigé B, Grévy JM, Rogalle P, Bellan J, Wilson M, Klaébé A, Pont F, Simon MF, Chap H. Gueguen G, et al. Biochemistry. 1999 Jun 29;38(26):8440-50. doi: 10.1021/bi9816756. Biochemistry. 1999. PMID: 10387090 - Structure-activity relationships of fluorinated lysophosphatidic acid analogues.
Xu Y, Aoki J, Shimizu K, Umezu-Goto M, Hama K, Takanezawa Y, Yu S, Mills GB, Arai H, Qian L, Prestwich GD. Xu Y, et al. J Med Chem. 2005 May 5;48(9):3319-27. doi: 10.1021/jm049186t. J Med Chem. 2005. PMID: 15857137 - Mitogenic action of lysophosphatidic acid and phosphatidic acid on fibroblasts. Dependence on acyl-chain length and inhibition by suramin.
van Corven EJ, van Rijswijk A, Jalink K, van der Bend RL, van Blitterswijk WJ, Moolenaar WH. van Corven EJ, et al. Biochem J. 1992 Jan 1;281 ( Pt 1)(Pt 1):163-9. doi: 10.1042/bj2810163. Biochem J. 1992. PMID: 1731751 Free PMC article. - Structure-activity relationships of lysophosphatidic acid analogs.
Lynch KR, Macdonald TL. Lynch KR, et al. Biochim Biophys Acta. 2002 May 23;1582(1-3):289-94. doi: 10.1016/s1388-1981(02)00183-x. Biochim Biophys Acta. 2002. PMID: 12069840 Review. - LPA and its analogs-attractive tools for elucidation of LPA biology and drug development.
Kano K, Arima N, Ohgami M, Aoki J. Kano K, et al. Curr Med Chem. 2008;15(21):2122-31. doi: 10.2174/092986708785747562. Curr Med Chem. 2008. PMID: 18781939 Review.
Cited by
- A lysophosphatidic acid analogue is revealed as a potent inhibitor of phosphatidylcholine synthesis, inducing apoptosis.
Gueguen G, Granci V, Rogalle P, Briand-Mésange F, Wilson M, Klaébé A, Tercé F, Chap H, Salles JP, Simon MF, Gaits F. Gueguen G, et al. Biochem J. 2002 Dec 1;368(Pt 2):447-59. doi: 10.1042/BJ20020273. Biochem J. 2002. PMID: 12197836 Free PMC article. - NHE3 mobility in brush borders increases upon NHERF2-dependent stimulation by lyophosphatidic acid.
Cha B, Zhu XC, Chen W, Jones M, Ryoo S, Zachos NC, Chen TE, Lin R, Sarker R, Kenworthy AK, Tse M, Kovbasnjuk O, Donowitz M. Cha B, et al. J Cell Sci. 2010 Jul 15;123(Pt 14):2434-43. doi: 10.1242/jcs.056713. Epub 2010 Jun 22. J Cell Sci. 2010. PMID: 20571054 Free PMC article. - Synthesis and Biological Evaluation of Lysophosphatidic Acid Analogues Using Conformational Restriction and Bioisosteric Replacement Strategies.
Abdelwahid MAS, Ohsawa K, Uwamizu A, Kano K, Aoki J, Doi T. Abdelwahid MAS, et al. ACS Omega. 2023 Dec 11;8(51):49278-49288. doi: 10.1021/acsomega.3c07668. eCollection 2023 Dec 26. ACS Omega. 2023. PMID: 38162765 Free PMC article. - Hen egg yolk and white contain high amounts of lysophosphatidic acids, growth factor-like lipids: distinct molecular species compositions.
Nakane S, Tokumura A, Waku K, Sugiura T. Nakane S, et al. Lipids. 2001 Apr;36(4):413-9. doi: 10.1007/s11745-001-0737-1. Lipids. 2001. PMID: 11383695 - Sphingosine-1-phosphate rapidly induces Rho-dependent neurite retraction: action through a specific cell surface receptor.
Postma FR, Jalink K, Hengeveld T, Moolenaar WH. Postma FR, et al. EMBO J. 1996 May 15;15(10):2388-92. EMBO J. 1996. PMID: 8665846 Free PMC article.
References
- Biochem J. 1992 Jan 1;281 ( Pt 1):163-9 - PubMed
- J Lipid Res. 1989 Apr;30(4):611-6 - PubMed
- Trends Cell Biol. 1994 Jun;4(6):213-9 - PubMed
- J Pharmacol Exp Ther. 1981 Oct;219(1):219-24 - PubMed
- Proc Natl Acad Sci U S A. 1993 Feb 15;90(4):1257-61 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous